Cargando…
423. SARS-CoV-2 NGS Assay Powered by Biotia COVID-DX Software
BACKGROUND: COVID-19 had spread quickly, causing an international public health emergency with an alarming global shortage of COVID-19 diagnostic tests. We developed and clinically validated a next-generation sequencing (NGS)-based target enrichment assay with the COVID-DX Software tailored for the...
Autores principales: | Nagy-Szakal, Dorottya, Couto-Rodriguez, Mara, Barrows, Joseph, Wells, Heather L, Debieu, Marilyne, Hager, Courteny, Butcher, Kristin, Chen, Siyuan, Boorstein, Robert, Mason, Christopher, O’Hara, Niamh B |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7777289/ http://dx.doi.org/10.1093/ofid/ofaa439.617 |
Ejemplares similares
-
Targeted Hybridization Capture of SARS-CoV-2 and Metagenomics Enables Genetic Variant Discovery and Nasal Microbiome Insights
por: Nagy-Szakal, Dorottya, et al.
Publicado: (2021) -
355. A Novel Likelihood-Based Model to Estimate SARS-CoV-2 Viral Titer from Next-Generation Sequencing Data
por: Wells, Heather L, et al.
Publicado: (2021) -
Monoclonal Antibody Therapy in a Vaccine Breakthrough SARS-CoV-2 Hospitalized Delta (B.1.617.2) Variant Case
por: Connor, Bradley A, et al.
Publicado: (2021) -
368. Performance Characteristics of Sequencing Assays for Identification of the SARS-CoV-2 Viral Genome
por: Antaki, Danny, et al.
Publicado: (2021) -
149. Extraction-free RT-PCR to Detect SARS-CoV-2 Variants of Concern
por: Harry, Brian L, et al.
Publicado: (2021)